SEC Form 4 · accession 0000899243-18-002737
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael N Needle
Officer — Chief Medical Officer
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 7:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.08 | Feb 1, 2018 | A | 225,000 | A | — | Feb 1, 2028 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal monthly installments from February 1, 2018, through February 1, 2022, subject to the Reporting Person's continued service to the Company.
Remarks
Exhibit 24 - Power of Attorney